United Kingdom

UK / Life Sciences Plan Takes Shape; Record Rise in Private Healthcare Use; MHRA’s New Regulatory Recognition Routes

UK / Pharma Industry Warns of Declining Competitiveness

The UK government has decided to go ahead with a much-debated increase in the revenue clawback rate —from 24.4 percent to 27.5 percent— for drugmakers subject to its Statutory Scheme…

Opinion / Vaccines Need to Stop the Spread of COVID or Protect against New Variants & Other Viruses to Disrupt Market & Reduce Healthcare Burden

Airfinity’s Dr Patricia Gallego highlights the persistent threat that COVID-19 continues to present to patients and healthcare systems around the world and outlines the urgent need for more vaccine breakthroughs…

RSV / Breakthrough Treatments Could Relegate Seasons Like 2023 To History Books

Dr Matt Linley, senior director for analytics and forecasting at predictive health analytics firm Airfinity, looks ahead to a potentially game-changing year in the fight against respiratory synctial virus (RSV),…

In Conversation

The latest news from UK healthcare and the life sciences, including a record rise in the number of people using private healthcare services due to significant strains on the National Health Service (NHS); reaction to the government’s latest Life Science Plan; and the Medicines and Healthcare products Regulatory Agency (MHRA)’s new regulatory recognition routes for medicines using approvals from Australia,…

UK / AbbVie & Lilly Exit Voluntary Pricing; Moderna Joins ABPI; Biotech Funding Downturn; Gilead NICE Approval

A roundup of the latest UK healthcare, pharma and biotech news including AbbVie and Lilly’s departure from the country’s voluntary medicines pricing agreement, Moderna’s expanded footprint, UK biotech’s 2022 funding…

Talent / The Essential Digital Skills for Pharma Leaders in 2023

What digital skills do pharma leaders need in order to drive transformation, deliver success at scale in the business, and prepare for next-gen customer engagement? Sarah Gilchriest explores the critical…

Medtech / Five Trends to Watch in 2023

Bernard Ross, a serial entrepreneur with more than 20 years’ senior experience at private and public board level across multiple industries, looks ahead to 2023 and highlights five key trends…

Biotech / Five Leadership Lessons from Redx Pharma CEO Lisa Anson

After an almost 20-year career in Big Pharma culminating in a role as president of AstraZeneca UK, Lisa Anson took the leap into the biotech world to lead what at…

Pricing & Market Access / What to Expect in 2023

Pricing and market access have become increasingly hot topics in recent years, as healthcare systems across the world attempt to balance their own financial sustainability with securing the latest medical…

UK / NHS CEO Talks Up Rapid Approvals, Accelerated Access & Efficiency

National Health Service (NHS) England CEO Amanda Pritchard has raised concerns about the state of British healthcare in recent weeks and months, proclaiming that the NHS is in a worse…

UK / AbbVie Buys DJS; Clinical Trial Decline an ‘Existential’ Threat to British Research; MHRA Accelerated Pathway for AvroBio Gene Therapy

With the brief tenure of Liz Truss as Prime Minister already drawing to a close, the UK faces yet another new leader as the country attempts to extricate itself from…

UK / Liz Truss & British Life Sciences' Uncertain Prospects

“Life sciences are at the heart of my vision to build a country fit for the future,” tweeted new UK Prime Minister Liz Truss last month. Now installed as leader…